Literature DB >> 7841967

Development of the kidney disease quality of life (KDQOL) instrument.

R D Hays1, J D Kallich, D L Mapes, S J Coons, W B Carter.   

Abstract

This paper describes the Kidney Disease Quality of Life (KDQOL) Instrument (dialysis version), a self-report measure that includes a 36-item health survey as the generic core, supplemented with multi-item scales targeted at particular concerns of individuals with kidney disease and on dialysis (symptom/problems, effects of kidney disease on daily life, burden of kidney disease, cognitive function, work status, sexual function, quality of social interaction, sleep). Also included were multi-item measures of social support, dialysis staff encouragement and patient satisfaction, and a single-item overall rating of health. The KDQOL was administered to 165 individuals with kidney disease (52% female; 48% male; 47% White; 27% African-American; 11% Hispanic; 8% Asian; 4% Native American; and 3% other ethnicities), sampled from nine different outpatient dialysis centres located in Southern California, the Northwest, and the Midwest. The average age of the sample was 53 years (range from 22 to 87), and 10% were 75 years or older. Internal consistency reliability estimates for the 19 multi-item scales exceeded 0.75 for every measure except one. The mean scores for individuals in this sample on the 36-item health scales were lower than the general population by one-quarter (emotional well-being) to a full standard deviation (physical function, role limitations due to physical health, general health), but similar to scores for dialysis patients in other studies. Correlations of the KDQOL scales with number of hospital days in the last 6 months were statistically significant (p < 0.05) for 14 of the 19 scales and number of medications currently being taken for nine of the scales. Results of this study provide support for the reliability and validity of the KDQOL.

Entities:  

Mesh:

Year:  1994        PMID: 7841967     DOI: 10.1007/bf00451725

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  21 in total

Review 1.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group.

Authors:  A Laupacis; C Wong; D Churchill
Journal:  Control Clin Trials       Date:  1991-08

Review 4.  Epoetin: a pharmacoeconomic review of its use in chronic renal failure and its effects on quality of life.

Authors:  R Whittington; L B Barradell; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

5.  Ongoing assessment of health status in patients with diabetes mellitus.

Authors:  D R Nerenz; D P Repasky; F W Whitehouse; D M Kahkonen
Journal:  Med Care       Date:  1992-05       Impact factor: 2.983

6.  The Functional Status Questionnaire: reliability and validity when used in primary care.

Authors:  A M Jette; A R Davies; P D Cleary; D R Calkins; L V Rubenstein; A Fink; J Kosecoff; R T Young; R H Brook; T L Delbanco
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

Review 7.  Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Consensus Development Conference Panel.

Authors: 
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

8.  Four-year cross-lagged associations between physical and mental health in the Medical Outcomes Study.

Authors:  R D Hays; G N Marshall; E Y Wang; C D Sherbourne
Journal:  J Consult Clin Psychol       Date:  1994-06

9.  Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

Authors:  M H Liang; M G Larson; K E Cullen; J A Schwartz
Journal:  Arthritis Rheum       Date:  1985-05

10.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study.

Authors:  A L Stewart; S Greenfield; R D Hays; K Wells; W H Rogers; S D Berry; E A McGlynn; J E Ware
Journal:  JAMA       Date:  1989-08-18       Impact factor: 56.272

View more
  331 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

2.  Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?

Authors:  A M Epstein; J Z Ayanian; J H Keogh; S J Noonan; N Armistead; P D Cleary; J S Weissman; J A David-Kasdan; D Carlson; J Fuller; D Marsh; R M Conti
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

3.  Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire.

Authors:  P Carmichael; J Popoola; I John; P E Stevens; A R Carmichael
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

4.  The SF36 as an outcome measure of services for end stage renal failure.

Authors:  J P Wight; L Edwards; J Brazier; S Walters; J N Payne; C B Brown
Journal:  Qual Health Care       Date:  1998-12

5.  Validation of the KDQOL-SF: a dialysis-targeted health measure.

Authors:  J C Korevaar; M P Merkus; M A M Jansen; F W Dekker; E W Boeschoten; R T Krediet
Journal:  Qual Life Res       Date:  2002-08       Impact factor: 4.147

6.  Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

Authors:  David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

7.  A Novel Application of a Biopsychosocial Theory in the Understanding of Disturbed Sleep before and after Kidney Transplantation.

Authors:  Jacob M Williams; Christina S McCrae; James R Rodrigue; Pamela R Patton
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

8.  Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study.

Authors:  Brian Bieber; Jiaqi Qian; Shuchi Anand; Yucheng Yan; Nan Chen; Mia Wang; Mei Wang; Li Zuo; Fan Fan Hou; Ronald L Pisoni; Bruce M Robinson; Sylvia P B Ramirez
Journal:  Nephrol Dial Transplant       Date:  2013-12-08       Impact factor: 5.992

9.  Sleep Duration and Health-Related Quality of Life in Predialysis CKD.

Authors:  Su-Ah Sung; Young Youl Hyun; Kyu Beck Lee; Hayne Cho Park; Wookyung Chung; Yeong Hoon Kim; Yong-Soo Kim; Sue Kyung Park; Kook-Hwan Oh; Curie Ahn
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-03       Impact factor: 8.237

10.  Feasibility of an Internet-based positive psychological intervention for hemodialysis patients with symptoms of depression.

Authors:  Rosalba Hernandez; Brett Burrows; Kenneth Wilund; Michael Cohn; Shuo Xu; Judith T Moskowitz
Journal:  Soc Work Health Care       Date:  2018-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.